Rethinking TREM2 as a target for Alzheimer’s disease after the INVOKE-2 trial failure

作者：Marco Colonna, David M. Holtzman · 发表于：Nature Medicine · 年份：2025 · DOI：10.1038/s41591-025-03816-2 · 被引用次数：22 · 研究领域：Inflammation biomarkers and pathways、Neuroinflammation and Neurodegeneration Mechanisms、Medicinal Plants and Bioactive Compounds